热门资讯> 正文
Dianthus Therapeutics推出1.5亿美元承销公开募股
2025-09-09 04:07
- Dianthus Therapeutics (NASDAQ:DNTH) has commenced an underwritten public offering of $150M of its shares of its common stock, pre-funded warrants to purchase shares of its common stock.
- Dianthus intends to use the net proceeds from this offering to advance the company’s preclinical and clinical development activities, as well as for working capital and general corporate purposes.
- DNTH -7.05% after hours to $29.46.
- Source: Press Release
More on Dianthus Therapeutics
- Seeking Alpha’s Quant Rating on Dianthus Therapeutics
- Historical earnings data for Dianthus Therapeutics
- Financial information for Dianthus Therapeutics
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。